Press Releases

05.14.2015

Bar Ilan University to work with Pfizer Inc. to evaluate drug delivery via DNA Nanorobots

05.14.2015

Marc Tessier-Lavigne, Ph.D. to Leave Pfizer Board of Directors

05.13.2015

Merck KGaA, Darmstadt, Germany, and Pfizer to Present Data at ASCO for Avelumab, an Investigational Anti-PD-L1 Antibody

05.11.2015

Pfizer Acquires Minority Interest in AM-Pharma; Secures Option to Acquire Company

05.06.2015

Pfizer Appoints New Leaders for BioTherapeutics Research & Development and Rinat

05.05.2015

23andMe Launches Lupus Research Community in Collaboration with Pfizer Inc.

04.28.2015

PFIZER REPORTS FIRST-QUARTER 2015 RESULTS

04.23.2015

Pfizer Hosts Annual Meeting Of Shareholders

04.21.2015

Pfizer Receives U.S. FDA Breakthrough Therapy Designation For XALKORI® (crizotinib) For The Treatment Of Patients With ROS1-Positive Non-Small Cell Lung Cancer

04.21.2015

Pfizer Phase 3 Study Of Inotuzumab Ozogamicin Meets Primary Endpoint In Adult Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia

04.20.2015

Global Strategic Partners Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Study with Avelumab* in Patients with Stage IIIb/IV Non-Small Cell Lung Cancer

04.16.2015

Pfizer Invites Public to Listen to Webcast of April 23 Annual Meeting of Shareholders